Technology News and Research

RSS

New study will examine why people live exceptionally long lives

Researchers at Washington University School of Medicine in St. Louis will head an ambitious study of people who live exceptionally long and healthy lives to identify the factors that account for their longevity.

10 Sep 2004

Unique technology with the potential to test for hundreds of diseases, cancers and genes in one, cheap, test

Queensland, Australia PhD student Angus Johnston has invented a unique technology with the potential to test for hundreds of diseases, cancers and genes in one, cheap, test. He hopes that within five years the technology will be available in a desktop unit for less than AU$30,000.

10 Sep 2004

New device aimed at detecting glaucoma

The physician who revolutionized screening methods for glaucoma nearly 20 years ago has patented a new device aimed at detecting glaucoma, a leading cause of blindness.

10 Sep 2004

Smallest patient to receive surgery to correct an abdominal disorder using an advanced surgical robotic system

After spending more than seven months in the hospital following his premature birth, the parents of Dakota Templeton were hopeful that his worst medical challenges were behind him. Unfortunately, those hopes were not realized.

10 Sep 2004

Transthyretin discovery may halt progression of Alzheimer's

In a finding that may cause a dramatic shift in the way scientists and researchers search for a therapy for Alzheimer's disease, a team of researchers led by Jeff Johnson, an associate professor at the School of Pharmacy, has discovered that increased expression of a protein called transthyretin in the brain appears to halt the progression of the disease.

10 Sep 2004

Magnetic resonance imaging helps measure osteoarthritis

Researchers from Australia's Monash University have revolutionised knee scans with the development of new technology that harnesses the power of magnetic resonance imaging (MRI).

10 Sep 2004

Painful and damaging chemotherapy may one day be a thing of the past

Researchers at the Georgia Institute of Technology and Purdue University have developed nano-sized particles that can target and trick cancer cells into absorbing them.

10 Sep 2004

Scientist rewarded for breaking down transplant rejection

A scientist from Australia's Monash University who has recently determined the structure of drug that is widely used as an immunosuppressant, will be presented the 2004 Science Minister's Prize for Life Scientist of the Year.

8 Sep 2004

Researchers uncover how HIV causes abnormalities in antibody-producing cells

HIV wreaks much of its damage by targeting the “orchestra conductor” of the immune system, a key class of T cells—CD4+ T cells—whose destructive relationship with HIV has been well-studied by AIDS researchers.

8 Sep 2004

Japanese research lab to use an IBM supercomputer for protein research

IBM announced today that AIST, a leading Japanese research laboratory, will use an IBM BlueGene/L supercomputer to advance their research in proteins, potentially accelerating breakthroughs in drug design. The BlueGene/L supercomputer has been ranked as the fourth largest supercomputer in the world.

8 Sep 2004

University of Utah gets patent approval relating to methods of rapid nucleic acid amplification

The U.S. Patent and Trademark Office has issued the University of Utah U.S. patent No. U.S. 6,787,338 (the '338 patent) relating to methods of rapid nucleic acid amplification.

8 Sep 2004

NMT Medical announces favorable patent decision

NMT Medical today announced a favorable decision by the U.S. Patent and Trademark Office Board of Appeals relating to the Company's patent infringement actions against AGA Medical Corp.

8 Sep 2004

Phase I clinical trial of new drug for severe asthma

Cambridge Antibody Technology today announced that it is starting a Phase I clinical trial of CAT-354, a human anti-IL-13 monoclonal antibody, which is a potential treatment for severe asthma, following recent approval from the Medicines and Healthcare products Regulatory Agency (MHRA).

8 Sep 2004

MorphoSys obtains license on human cell line technology for use in its antibody research

MorphoSys has announced today a non-exclusive license agreement with Dutch biotechnology company Crucell and DSM Biologics.

8 Sep 2004

New IBM technology could bring the promise of personalized medicine one step closer

Using a basic computer language, the researchers created a "smart" DNA stream that contains a patient's entire medical record

8 Sep 2004

Enhanced technology with improved features drives the mobile medical imaging equipment market

The increasing demand for digitisation among hospitals and high price of static modalities are driving demand for mobile medical imaging equipment.

8 Sep 2004

Pioneering work with human embryonic stem cells could speed up development of new treatments for Parkinson’s and diabetes

Pioneering work with human embryonic stem (hES) cells could speed up the development of new treatments for a range of degenerative disorders such as Parkinson’s disease and diabetes according to Dr Stephen Minger of King’s College London, speaking today at the BA Festival of Science.

8 Sep 2004

First biological assessment tool for Attention Deficit Hyperactivity Disorder

On the eve of the first National ADHD Awareness Day, the first biological assessment tool for Attention Deficit Hyperactivity Disorder is being introduced in Denver.

7 Sep 2004

Phico Therapeutics secures funding to tackle superbug

Phico Therapeutics Ltd, a Cambridge-based company that has developed a unique anti-bacterial technology to treat the hospital superbug, MRSA, has raised £550,000 with the help of Oxfordshire Investment Opportunity Network, Europe’s leading technology business angel network.

6 Sep 2004

Protein-rich teething rusk to help stop children suffering Kwashiorkor

Two food technology students from RMIT University, Australia, who developed a teething rusk for malnourished children in developing countries have won a national award.

4 Sep 2004